http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012268272-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_326176b13d13f046c10a2ba6e0b84f10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate | 2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a6f590df1bed2a1073a24f8fb5b9b8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fb6f1bd6f538fc2fe4fe8244466b274 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bba101aa26ab252d80cfa346b0382a76 |
publicationDate | 2013-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2012268272-A1 |
titleOfInvention | Cell populations having immunoregulatory activity, method for isolation and uses |
abstract | The present invention provides a population of connective tissue derived cells that respond to interferon-gamma (IFN-y) by expressing indolamine-2,3-dioxygenase (IDO) for use in preventing, treating or ameliorating one or more symptoms associated with disorders in which modulation of a subject's immune system is beneficial, including, but not limited to, autoimmune diseases, inflammatory disorders, and immunologically mediated diseases including rejection of transplanted organs and tissues. |
priorityDate | 2005-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1360.